Loading organizations...
Limulus Venture Partners is a venture capital firm investing in the biotechnology sector. The firm identifies and supports early-stage companies developing innovative solutions across various therapeutic areas and life science tools. Their investment strategy targets ventures poised to address significant unmet medical needs through scientific advancements and novel technological platforms.
Founded in December 2015, Limulus Venture Partners emerged from an understanding of the intricate challenges and significant opportunities within the life sciences industry. The firm's establishment reflected a commitment to fostering groundbreaking research and development, driven by the insight that specialized capital and strategic guidance are crucial for biotech ventures to mature.
The firm primarily backs emerging biotechnology companies and their scientific teams. Limulus Venture Partners envisions accelerating the development of transformative healthcare solutions, ultimately aiming to bring life-changing therapies to patients. They seek to be a foundational partner in the journey from scientific discovery to clinical impact.
Limulus Venture Partners has 4 tracked investments across 2 companies. The latest tracked deal is $58.0M Series D in Tricida in November 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 1, 2017 | Tricida | $58.0M Series D | — | Atlas Venture, OrbiMed, Cormorant Asset Management, Longitude Capital, Sibling Capital Ventures, Venrock, Vivo Capital, Wellington Management |
| Jul 1, 2016 | Tricida | $55.0M Series C | David Hirsch | Atlas Venture, OrbiMed, Sibling Capital Ventures, Vivo Capital |
| Jul 23, 2015 | Ra Pharmaceuticals | $58.5M Series B | Lightstone Ventures, Novo Ventures, Rajeev Shah | Amgen Ventures, Morgenthaler Ventures, NEW Enterprise Associates, Novartis, Rock Springs Capital |
| Mar 1, 2015 | Tricida | $30.0M Series B | OrbiMed | Atlas Venture, Sandra Coufal |
